C

ChemoCentryx Inc
F:2CX

Watchlist Manager
ChemoCentryx Inc
F:2CX
Watchlist
Price: 51.89 EUR Market Closed
Market Cap: 3.7B EUR

Wall Street
Price Targets

2CX Price Targets Summary
ChemoCentryx Inc

There are no price targets for 2CX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ChemoCentryx Inc Competitors:
Price Targets
OXB
Oxford BioMedica PLC
30% Upside
IONS
Ionis Pharmaceuticals Inc
10% Upside
2157
Lepu Biopharma Co Ltd
95% Upside
CELC
Celcuity Inc
11% Upside
ADAG
Adagene Inc
417% Upside
VCEL
Vericel Corp
56% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
50% Upside
1530
3SBio Inc
47% Upside

Revenue
Forecast

Revenue Estimate
ChemoCentryx Inc

For the last 8 years the compound annual growth rate for ChemoCentryx Inc's revenue is 23%. The projected CAGR for the next 2 years is 139%.

23%
Past Growth
139%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ChemoCentryx Inc

Operating Income forecast
is not available for
ChemoCentryx Inc

Net Income
Forecast

Net Income Estimate
ChemoCentryx Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2CX's stock price target?
Not Available

2CX doesn't have any price targets made by Wall Street professionals.

What is ChemoCentryx Inc's Revenue forecast?
Projected CAGR
139%

For the last 8 years the compound annual growth rate for ChemoCentryx Inc's revenue is 23%. The projected CAGR for the next 2 years is 139%.

Back to Top